What is Tarsus Pharmaceuticals Inc?
, a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 3.96B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 1679,391 shares $5.4M | 0 |
| 9-12months | 213,397 shares $1.1M | 0 |